These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32122729)

  • 1. Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma.
    Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; Tian Z; Larcher A; Capitanio U; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Urol Oncol; 2020 May; 38(5):537-544. PubMed ID: 32122729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases.
    Dell'Oglio P; Larcher A; Muttin F; Di Trapani E; Trevisani F; Ripa F; Carenzi C; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U
    Urol Oncol; 2017 Nov; 35(11):662.e9-662.e15. PubMed ID: 28801027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
    Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
    Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation.
    Nocera L; Collà Ruvolo C; Stolzenbach LF; Wenzel M; Tian Z; Larcher A; Capitanio U; Mirone V; Tilki D; Chun FKH; Kapoor A; Shariat SF; Saad F; Montorsi F; Briganti A; Karakiewicz PI
    Eur Urol Focus; 2022 Jan; 8(1):182-190. PubMed ID: 33653677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion.
    Capitanio U; Deho' F; Dell'Oglio P; Larcher A; Capogrosso P; Nini A; Carenzi C; Freschi M; Briganti A; Salonia A; Montorsi F; Bertini R
    World J Urol; 2016 Aug; 34(8):1139-45. PubMed ID: 26670425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
    Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
    Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
    BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1-4 cm renal cell carcinomas.
    Rosiello G; Pecoraro A; Luzzago S; Deuker M; Stolzenbach LF; Tian Z; Larcher A; Capitanio U; Montorsi F; Shariat SF; Kapoor A; Saad F; Briganti A; Karakiewicz PI
    Cancer Causes Control; 2021 Feb; 32(2):119-126. PubMed ID: 33169306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
    Geller JI; Cost NG; Chi YY; Tornwall B; Cajaiba M; Perlman EJ; Kim Y; Mullen EA; Glick RD; Khanna G; Daw NC; Ehrlich P; Fernandez CV; Dome JS;
    Cancer; 2020 Dec; 126(23):5156-5164. PubMed ID: 32926409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromophobe renal cell carcinoma: a clinicopathological study of 16 cases].
    Nakaigawa N; Yao M; Kondo K; Kishida T; Noguchi K; Kubota Y; Nagashima Y; Kawano N; Inayama Y; Nozawa A
    Hinyokika Kiyo; 2006 Jan; 52(1):1-6. PubMed ID: 16479980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.
    Jamal M; Taneja K; Arora S; Barod R; Rogers CG; Sanchez J; Gupta NS; Williamson SR
    Int J Surg Pathol; 2018 Sep; 26(6):536-541. PubMed ID: 29560759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma.
    Muttin F; Pecoraro A; Larcher A; Dell'Oglio P; Nini A; Cianflone F; Trevisani F; Dehò F; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U
    World J Urol; 2019 Apr; 37(4):701-708. PubMed ID: 30046844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy.
    Bandini M; Smith A; Zaffuto E; Pompe RS; Marchioni M; Capitanio U; Chun FK; Kapoor AB; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
    World J Urol; 2018 Jan; 36(1):51-57. PubMed ID: 29022072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study.
    Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Rosiello G; Tian Z; St-Hilaire PA; Shariat SF; Saad F; Lavallée L; Briganti A; Kapoor A; Fiori C; Porpiglia F; Karakiewicz PI
    Eur Urol Focus; 2021 Jul; 7(4):818-826. PubMed ID: 32169361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis.
    Kaushik D; Linder BJ; Thompson RH; Eisenberg MS; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA
    Urology; 2013 Jul; 82(1):136-41. PubMed ID: 23642851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.